Down syndrome (DS) is the most common genetic cause of intellectual disability and a huge biomedical problem of increasing concern. Currently, there are no treatments that can prevent, delay, or restore deficits in learning and memory associated with DS. Thus, the identification of novel neuronal targets for the development of pharmacotherapies to treat memory decline associated with DS is an important goal. It has been hypothesized that alterations in protein synthesis (mRNA translation) could contribute to the molecular, synaptic, and behavioral abnormalities of neurodevelopmental disorders, but whether dysfunctional protein synthesis is responsible for the DS pathology remains unknown. The goal of this competing renewal is to identify and correct the aberrant translational control program underlying DS pathophysiology. We focus on protein synthesis controlled by the PKR-eIF2? signaling pathway because a) our preliminary findings indicate that PKR-eIF2? signaling is selectively perturbed in the DS brain, and b) during the previous funding period, we discovered PKR-eIF2? signaling as a central mechanism regulating not only the formation of long-term memory, but also the two major and opposing forms of synaptic plasticity in the brain. We will combine genetics, state-of-the-art intersectional molecular genetic approaches, pharmacology, electrophysiology, cell- type-specific manipulation, genomics, and behavior to define the translational and synaptic plasticity mechanisms underlying cognitive deficits in Down syndrome. We anticipate that the results of these Aims will provide new fundamental insights into the biological basis of intellectual disability and could open avenues for new therapies.
Down syndrome is the most common genetic cause of intellectual disability and a huge biomedical problem, but little is known about the underlying molecular mechanism. By using a multidisciplinary approach that combines mouse genetics, molecular biology, electrophysiology, pharmacology, human-derived neurons, and behavioral studies, we aim to decipher whether aberrant synthesis of proteins controlled by PKR-eIF2? signaling pathway, in different cell types, underlies the pathophysiology of Down syndrome. By providing new fundamental insights into the biological basis of Down syndrome, these studies could also lead to the development of new treatments for intellectual disabilities.
|Zhu, Ping Jun; Chen, Chien-Ju; Mays, Jacqunae et al. (2018) mTORC2, but not mTORC1, is required for hippocampal mGluR-LTD and associated behaviors. Nat Neurosci 21:799-802|
|Buffington, Shelly A; Di Prisco, Gonzalo Viana; Auchtung, Thomas A et al. (2016) Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring. Cell 165:1762-1775|
|Johnson, Jennifer L; Huang, Wei; Roman, Gregg et al. (2015) TORC2: a novel target for treating age-associated memory impairment. Sci Rep 5:15193|
|Huber, Kimberly M; Klann, Eric; Costa-Mattioli, Mauro et al. (2015) Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism. J Neurosci 35:13836-42|
|Pitcher, Meagan R; Herrera, José A; Buffington, Shelly A et al. (2015) Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene. Hum Mol Genet 24:2662-72|
|Di Prisco, Gonzalo Viana; Huang, Wei; Buffington, Shelly A et al. (2014) Translational control of mGluR-dependent long-term depression and object-place learning by eIF2?. Nat Neurosci 17:1073-82|
|Buffington, Shelly A; Huang, Wei; Costa-Mattioli, Mauro (2014) Translational control in synaptic plasticity and cognitive dysfunction. Annu Rev Neurosci 37:17-38|
|Meng, Linyan; Person, Richard Erwin; Huang, Wei et al. (2013) Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model. PLoS Genet 9:e1004039|
|Costa-Mattioli, Mauro; Monteggia, Lisa M (2013) mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 16:1537-43|
|Huang, Wei; Zhu, Ping Jun; Zhang, Shixing et al. (2013) mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat Neurosci 16:441-8|
Showing the most recent 10 out of 11 publications